The role of the degree of oligomerization in the structure and function of human surfactant protein A (SP-A) was investigated using a human SP-A1 mutant (SP-A1 ⌬AVC,C6S ), expressed in mammalian cells, resulting from site-directed substitution of serine for Cys 6 and substitution of a functional signal peptide for the cysteine-containing SP-A signal sequence. This Cys 6 mutant lacked the NH 2 -terminal Ala ؊3 -Val ؊2 -Cys ؊1 (⌬AVC) extension present in some SP-A1 isoforms. SP-A1
Surfactant protein A (SP-
is a large oligomeric extracellular protein primarily found in the alveolar fluid of mammals. SP-A is a lipid-binding protein, a property that allows it to position and concentrate along with the extracellular membranes that line the alveolar epithelium and constitute the pulmonary surfactant. Thus, surfactant membranes containing SP-B and SP-C are bedecked with SP-A, which interacts primarily at bilayer surfaces. In relation to the surfactant system, SP-A catalyzes the formation of tubular myelin, improves the adsorption and spreading of surfactant membranes onto an air-liquid interface, and protects surfactant biophysical activity from the inhibitory action of serum proteins (1) (2) (3) . At the same time, this tight binding of SP-A to surfactant membranes makes possible its strategic location at the front lines of defense against inhaled pathogens, toxins, and allergens. SP-A recognizes pathogen-associated molecular patterns on microorganisms, resulting in aggregation, opsonization, or permeabilization of microorganisms and facilitation of microbial clearance (1, 4 -7) . Moreover, SP-A is capable of direct interaction with epithelial and immune cells in the alveolus through binding to cell membrane receptors. This results in modulation of immune cell functions such as phagocytosis of pathogens and apoptotic cells, chemotaxis, proliferation, cytokine production, respiratory burst, and expression of surface receptors (1, 6 -9) . Thus, SP-A is involved in innate host-defense and inflammatory immunomodulator processes of the lung, as demonstrated by experiments with mice deficient in SP-A. These SP-A knockout mice show increased susceptibility to bacterial and viral infections (10) and enhanced inflammatory responses in the lung to a variety of stimuli (11) .
The binding capabilities of SP-A to surfactant membranes, pathogen-associated molecular patterns, and receptors on cell surfaces depend on its complex structure. SP-A belongs to the structurally homologous family of innate immune defense proteins known as collectins for their collagen-like and lectin domains. The primary structure of mature SP-A is conserved among different mammals with some differences. It consists of four structural domains: 1) an NH 2 -terminal segment involved in intermolecular disulfide bond formation; 2) a collagen-like domain characterized by 23 Gly-X-Y repeats with an interruption near the midpoint of the domain; 3) an ␣-helical coiled-coil domain, which constitutes the neck region between the collagen and the globular domain; and 4) a COOH-terminal globular domain involved in phospholipid binding and in Ca 2ϩ -dependent binding of oligosaccharides (12, 13) . SP-A is modified after translation (cleavage of the signal peptide, proline hydroxylation, and Asn 187 -linked glycosylation). Unlike SP-As from other mammalian species, baboon and human SP-As consist of two polypeptide chains, SP-A1 and SP-A2. The major differences between mature SP-A1 and SP-A2 are in the collagen domain (14) .
The oligomerization domains in SP-A and other collectins are the coiled-coil domain, collagen triple helices, and the NH 2 -terminal segment. SP-A oligomerization is an intracellular process that is thought to occur in a zipper-like fashion along the C-terminal to N-terminal axis, as reported for other collectins (SP-D and MBL-C) (15, 16) . Triple-helix formation from three polypeptide chains requires previous trimerization of COOH-terminal globular domains by a trimeric ␣-helical coiled-coil (13, 17, 18) . Octadecamers appear to be formed by lateral association of the NH 2 -terminal half of six triple-helical stems, forming a microfibrillar end piece stabilized by disulfide bonds at the NH 2 -terminal region (19, 20 ) (see Fig. 1 ). In rat SP-A two cysteine residues are involved in multimer formation: a cysteine in the 6 position of the NH 2 -terminal segment (17) and another cysteine in the position Ϫ1, which is the last position of the signal peptide, one amino acid before the NH 2 terminus (18) . Human SP-A, as well as recombinant human SP-A1 and SP-A2, expressed in mammalian or insect cells, also has considerable NH 2 -terminal heterogeneity, in which about 50 -75% of human SP-A molecules contain Cys Ϫ1 isoforms (18, (21) (22) (23) . In human SP-A1, four cysteine residues are potentially involved in the arrangement of the disulfide bonding: two cysteine residues in the NH 2 -terminal segment (Cys Ϫ1 and Cys 6 ), another in the middle of the collagen-like sequence within the Pro-Cys-Pro-Pro interruption (Cys 48 ), and a fourth cysteine at position 65 (Cys 65 ) in the collagen domain near the neck. Cys 65 is substituted by Arg 65 in the human SP-A2 polypeptide chain (14) .
The first objective of this study was the production of a full-length mammalian cell-derived SP-A1 molecule that was not capable of forming higher oligomers than trimers. To this end, the cysteine at position ϩ6 was removed by site-direct mutagenesis (Ser was substituted for Cys 6 ). In addition, human IgG light-chain signal sequence was substituted for SP-A1 signal sequence to abolish the Cys Ϫ1 isoforms. The combined mutation eliminates potential inter-chain disulfide cross-linking within the NH 2 -terminal portion of the molecule. Using this approach, we produced a full-length mutant SP-A molecule (SP-A1 ⌬AVC,C6S ) that is secreted as a trimer, utilizing a CHO K1 cell expression system. The second objective was the analysis of the structure and function of SP-A1
⌬AVC,C6S in comparison with wild type recombinant human SP-A1, expressed in the same system, which has a supratrimeric assembly and is functionally comparable to the protein isolated from lung lavages of healthy subjects (22) .
Although several studies have indicated the importance of the degree of oligomerization in mannose-binding protein and mammalian cell-derived SP-D (24 -26) , none have dealt with the functional importance of supratrimeric assembly in SP-A expressed in mammalian cells. These results are important in understanding the consequences of incomplete oligomerization, because the extent of oligomerization of human SP-A may be altered in various disease states and can vary among individuals (27) . Incomplete oligomerization occurs in insect cell-derived human SP-A1, which consists mainly of trimers and hexamers and low levels of higher oligomers (22, 23) . Insect cells lack prolyl 4-hydroxylase activity. The lack of hydroxyproline perturbs the folding of recombinant human SP-A1, which influences the arrangement of disulfide bonding, affecting the oligomerization of nascent hydroxyproline-deficient SP-A1 (22) .
In this study we report for the first time that the supratrimeric assembly is essential for the stabilization of the collagen triple helix of mammalian cell-derived human SP-A1 at physiological temperatures. The collagen triple helix of SP-A1 ⌬AVC,C6S is partially unfolded at 37°C, which increases the susceptibility of the protein to proteolytic degradation. In addition, our results show that supratrimeric assembly of human SP-A1 is essential for 1) Ca 2ϩ -dependent SP-A self-association, 2) the capability of SP-A to induce aggregation of membranes and LPS micelles, and 3) the ability of SP-A to enhance surfactant interfacial adsorption. However, supratrimeric assembly is not essential for the binding of human SP-A to phospholipids and rough-LPS and for the anti-inflammatory activity of SP-A.
EXPERIMENTAL PROCEDURES
Materials-Synthetic phospholipids, DPPC and DPPG, were purchased from Avanti Polar Lipids (Birmingham, AL), and their homogeneity was routinely tested on thin-layer chromatography. Dansyl-DHPE, fluorescein, and fluorescenin-5-isothiocyanate (FITC, isomer I) were obtained from Molecular Probes (Eugene, OR). Rough LPS from Salmonella minnesota (serotype Re-595), smooth LPS from Escherichia coli (serotype 055:B5), FITC-LPS from E. coli (serotype 055:B5), trypsin from bovine pancreas, phorbol 12-myristate 13-acetate, and PHA were purchased from Sigma Co. The organic solvents (methanol and chloroform) used to dissolve lipids were high-performance liquid chromatography grade (Scharlau, Barcelona). RPMI 1640 medium, heat-inactivated fetal bovine serum, and a Limulus amebocyte lysate kit were obtained from Bio-Whittaker (Walkersville, MD). Gradient SDS-PAGE gels were from NOVEX (Invitrogen). An enzyme-linked immunosorbent assay kit for TNF-␣ immunoassays was obtained from BD Pharmingen (San Diego, CA). Macrophage-like cell line U937 cells were supplied by the American Type Culture Collection (Manassas, VA). Anti-CD14 (28C5) was kindly provided by Dr. Peter Tobias (The Scripps Research Inst., La Jolla, CA). All other reagents were of analytical grade obtained from Merck.
Expression and Purification of Recombinant Human SP-A1-The recombinant wild-type form of human SP-A1 (6A 2 allele) was expressed in stably transformed CHO K1 cells as described by Voss et al. (19) and purified from culture supernatant by mannose affinity chromatography. Endotoxin content was 200 pg/mg of SP-A1 as determined by Limulus amebocyte lysate assay.
Cloning and Expression of Recombinant Human SP-A1
⌬AVC,C6S Mutant-The genomic DNA sequence of the human SP-A1 gene contained in the expression vector as described in Voss et al. (19) , was subcloned into the expression vector pEFmyc/cyto (Invitrogen) in which the myc epitope was removed after digestion with NotI/XbaI. Furthermore, the signal sequence of SP-A1 was replaced by the signal sequence V21G of the light chain of a human IgG. The expression plasmid was introduced into CHO K1 cells by polyfectamine (Invitrogen) as transfection reagent using standard conditions. Stably expressing cell clones were selected in 1 mg/ml G418 and subsequently subcloned by limited dilution. For expression, the cells were grown in roller bottles using serum-free Dulbecco's modified Eagle's medium/Ham's F-12 supplemented with 10 mM Hepes and 1 mM ascorbate for hydroxylation as described previously (19) .
Purification of Recombinant Human SP-A1 ⌬AVC,C6S Mutant-Given that SP-A1 ⌬AVC,C6S trimers are poorly isolated by mannose affinity chromatography, we have developed a new method of SP-A isolation.
SP-A1
⌬AVC,C6S trimers were purified from culture supernatant by anionic exchange chromatography, size exclusion chromatography, and hydrophobic interaction chromatography.
All chromatography steps were carried out at room temperature on an extendedÄkta Purifier chromatography system (Amersham Biosciences), using sterile buffers. Typically, 5 liters of cell culture supernatant were centrifuged at 11,000 ϫ g for 1 h, at 4°C in a Sorvall Evolution RC centrifuge using a SLC-6000 rotor (Kendro Laboratory Products). The resulting supernatant was diluted with one volume of anionic exchange chromatography buffer A (20 mM borate, pH 10) to decrease conductivity, and subsequently sterilized by filtration (ZapCap Plus, 0.2 m, Schleicher & Schuell, Dassel, Germany). The resulting 10-liter sample was then passed through a 50-ml Resource Q anion exchanger column (Amersham Biosciences) at 478 ml/h. Bound protein was eluted with a salt gradient elution, ranging from 0 to 45% anionic exchange chromatography buffer B (20 mM borate, pH 10, 1 M NaCl) at 190 ml/h flow rate. Fractions containing SP-A1 ⌬AVC,C6S were pooled, concentrated, and buffered into size exclusion chromatography running buffer (25 mM Tris/HCl, pH 7.5, 0.15 M NaCl; 2 mM EDTA; 0,02% NaN 3 ) using an Amicon stirring chamber (Millipore, Schwalbach, Germany) with a 30-kDa cutoff nitrocellulose membrane. Two milliliters of the sample were then applied to a 300-ml Superdex 200 column (Amersham Biosciences) at a flow rate of 28 ml/h. Fractions eluting at an apparent molecular mass of 105 kDa contained SP-A1
⌬AVC,C6S
. These fractions were pooled, concentrated, and buffered into hydrophobic interaction chromatography buffer A (25 mM Tris/HCl, pH 7.5, 0.8 M (NH 4 ) 2 SO 4 ). After sterile filtration, a volume of 14 ml was applied to a 20-ml Phenyl-Sepharose HP column (Amersham Biosciences) at 90 ml/h, and SP-A1 ⌬AVC,C6S was eluted with a salt gradient elution, from 0 to 100% hydrophobic interaction chromatography buffer B (25 mM Tris/HCl, pH 7.5). Subsequently, the buffer was exchanged for 10 mM NaHPO 4 , pH 7.5, and the protein concentration was adjusted to 2 mg/ml. The endotoxin content was Ͻ0.5 enzyme units/mg SP-A (50 pg/mg SP-A) as determined by the Limulus amebocyte lysate assay. The purity of the final product was Ͼ95% according to the quantification using the Agilent Bioanalyzer 2100 system and the Protein 200 plus LabChip Kit (Agilent Technologies, Waldbronn, Germany). The suitability of this new method of SP-A isolation was checked with human SP-A from alveolar proteinosis. Human SP-A isolated by this new method exhibited structural and functional properties similar to the protein isolated by butanol and octylglucoside extractions (28) , but the endotoxin content was much lower. 2 Isolation of Human SP-A-Bronchoalveolar lavages from alveolar proteinosis patients were used as a source of human SP-A. SP-A was purified from isolated surfactant using sequential butanol and octylglucoside extractions (28) Endotoxin content of natural human SP-A isolated by this method was about 300 pg of endotoxin/mg of SP-A, as determined by Limulus amebocyte lysate test. Quantification of SP-A was carried out by amino acid analysis in a Beckman System 6300 High Performance analyzer as described elsewhere (29) .
Protein Microsequencing-The NH 2 -terminal amino acid sequence of SP-A1 and SP-A1 ⌬AVC,C6S was determined using a modification of the technique of Edman degradation on an automated gas phase microsequencer (ABI Protein sequencer) as described previously (30) . Proteins were submitted for analysis bound to polyvinylidene difluoride membranes after transfer from SDS-PAGE. The relative percentage of the SP-A isoforms was estimated by comparison of the molecular yield of representative amino acids from each sequence.
Polyacrylamide Gel Electrophoresis-Purity and apparent molecular weights of monomeric SP-As were determined by 12% SDS-PAGE under reducing conditions (5% ␤-mercaptoethanol). Proteins were visualized by silver stain (22) . Pre-stained See Blue (NOVEX) was used as molecular weight marker.
To determine the assembly of disulfide-linked polypeptide chains of SP-A samples, 50 ng of each of the SP-As was separated on a precasted 4 -12% gradient SDS-PAGE under non-reducing conditions. The SP-A proteins were detected by Western blotting using anti-human SP-A anti-serum raised in rabbits in a dilution of 1:100,000 and were visualized by chemiluminescence. The molecular weight of the disulfidelinked oligomers was determined by comparison with a molecular weight standard. For native conditions, electrophoresis was performed at 4°C with a 7% Tris acetate polyacrylamide gel (NOVEX) in the absence of reducing agents as described previously (22) .
Electron Microscopy-The sample preparation for electron microscopy was carried out as described in a previous study (19) . 25 ng of SP-A1 and SP-A1 ⌬AVC,C6S was dissolved in 0.2 M ammonium bicarbonate, pH 7.9, mixed with an equal volume of glycerol, and immediately sprayed onto freshly cleaved mica. Rotary shadowing by platinum/ carbon and electron microscopy was done following protocols described previously (31) .
CD Measurements-CD spectra were obtained on a Jasco J-715 spectropolarimeter fitted with a 150-watt xenon lamp (22, 23, 32) . Quartz cells with a 1-mm path length were used, and the spectra were recorded in the far-UV region (190 -260 nm) at the indicated temperature. Four scans were accumulated and averaged for each spectrum. The acquired spectra were corrected by subtracting the appropriate blanks, subjected to noise-reduction analysis, and presented as molar ellipticities (degrees⅐cm 2 ⅐dmol Ϫ1 ) assuming 110 Da as the average molecular mass per amino acid residue. All measurements were typically performed in 5 mM Tris-HCl buffer, pH 7.4, in the absence or presence of 1 mM calcium and 150 mM NaCl. Protein concentration in all cases was 120 g/ml and was determined by amino acid analysis.
For the analysis of thermal stability of the collagen-like domain of recombinant human SP-As, melting curves were monitored at 207 nm while the sample temperature was raised from 10 to 70°C, with an average heating rate of 12°C/h. SP-A concentrations were 120 g/ml, and quartz cells with a 1-mm path length were used. The folded fraction was calculated from the equation: Trypsin Digestion-To determine the protease sensitivity of SP-A1 and SP-A1
⌬AVC,C6S at temperatures above and below the T m of the corresponding protein, the recombinant proteins (2 g) were incubated with trypsin (0.13 g) in 5 mM Tris-HCl buffer (pH 7.4) as described before (32, 33) . The mixtures were incubated during 30 min at 25, 37, and 50°C. The digestion was stopped by addition of reducing SDS-PAGE sample buffer containing phenylmethylsulfonyl fluoride followed by boiling. Samples were analyzed by SDS-PAGE followed by silver stain. To test the effect of the binding of Ca 2ϩ to SP-A on trypsin susceptibility, SP-A1 and SP-A1
⌬AVC,C6S were incubated in a 5 mM Tris-HCl buffer (pH 7.4) containing 100 mM NaCl, and 1 mM CaCl 2 for 10 min prior to 30-min incubation with trypsin at the indicated temperatures.
Intrinsic Fluorescence-Fluorescence measurements were carried out using an SLM-Aminco AB-2 spectrofluorometer with a thermostatted cuvette holder (Ϯ0.1°C), using 5 ϫ 5 mm path-length quartz cuvettes. Fluorescence emission spectra of human SP-A (7 g/ml) were measured at 25°C in 5 mM Tris-HCl buffer (pH 7.4) containing either 2 mM Ca 2ϩ or 2 mM EDTA (22, 23, 29) . The blanks and protein samples were excited at 275 nm for measuring the total protein fluorescence spectrum. The slit widths were 4 nm for the excitation and emission beams. Emission spectra were recorded from 300 to 400 nm.
Fluorescence Assays to Determine the Binding of SP-A to FITC-Re-LPS-A fluorescent Re-LPS derivative (FITC-Re-LPS)
in which the phosphoethanolamine groups of Re-LPS were bound to fluorescein isothiocyanate (FITC) was prepared by the method described before (34) . The Re-LPS concentration of the fluorescent derivative was determined by quantification of the 2-keto-3-deoxyoctulosonic acid, and the content of fluorescein was determined by optical density at 493 nm as described (34) . Typically, the fluorescent Re-LPS derivative had substitution ratios of 15-20 mol% fluorescein. Fluorescence emission spectra of FITCRe-LPS (1 g/ml) were measured in the presence and absence of SP-A (50 g/ml) in 150 mM NaCl, 1 mM EDTA, 5 mM Tris-HCl buffer (pH 8) at 25°C. The blanks (protein alone) and FITC-Re-LPS samples (with and without protein) were excited at 470 nm, and emission spectra were recorded from 500 to 650 nm. Fluorescence emission anisotropy measurements were obtained with Glan Prism polarizers. Excitation and emission wavelengths were set at 470 and 520 nm, respectively. For each sample, fluorescence emission intensity data in parallel and perpendicular orientations with respect to the exciting beam were collected ten times each and then averaged. Anisotropy, r, was calculated as,
where I and I Ќ are the parallel and perpendicular polarized intensities measured with the vertically polarized excitation light, and G is the monochromator grating correction factor.
Fluorescence Resonance Energy Transfer Assay to Determine the Binding of SP-A to
Phospholipid Vesicles-DPPC vesicles containing different mol % of dansyl-DHPE (from 0 -5 mol%) were prepared at the indicated phospholipid concentrations (5, 10, 20, 40, or 60 g/ml) by hydrating dry lipid films in buffer A containing 100 mM NaCl, 0.1 mM EDTA, 5 mM Tris-HCl (pH 7.4) and allowing them to swell for 1 h at 51°C. After vortexing, the resulting multilamellar vesicles were sonicated at the same temperature during 2 min at 390 watts/cm 2 (burst of 0.6 s, 0.4 s between bursts) in a UP 200S sonifier with a 2-mm microtip. Unilamellar vesicles were prepared freshly each day, just before start-ing the experiment. The final lipid concentration was assessed by phosphorus determination. For vesicle-size analysis in solution, quasi-elastic light scattering was used as recently described (35) . DPPC vesicles prepared by sonication consisted of a major population (70%) of unilamellar vesicles (mean diameter of 105 Ϯ 6 nm) and a minor population (30%) of multilamellar vesicles (mean diameter of ϳ2 m) that were removed by centrifugation. The maximum excitation and emission wavelengths of dansyl-DHPE/DPPC vesicles in buffer A were 340 and 523 nm, respectively. Fluorescence resonance energy transfer (FRET) from SP-A tryptophan residues to the dansyl extrinsic probe incorporated in DPPC vesicles was performed in buffer B containing 100 mM NaCl, 0.2 mM Ca 2ϩ , 5 mM Tris-HCl buffer (pH 7.4) at 25°C with 10 g/ml of SP-A. Fluorescence emission intensity was recoded from 300 to 554 nm after excitation at 282 nm. The slit widths were 4 nm for the excitation and emission beams.
SP-A Self-association Assay-Self-association assays of SP-A were performed as described previously (22, 36) by measuring the Ca 2ϩ -dependent change in protein absorbance at 360 nm in a Beckman DU-640 spectrophotometer.
Re-LPS and Phospholipid Vesicle Aggregation Assays-DPPC/DPPG (7:3) (w/w) vesicles were prepared at a phospholipid concentration of 1 mg/ml by hydrating dry lipid films in a buffer containing 150 mM NaCl, 0.1 mM EDTA, 5 mM Tris-HCl (pH 7.4), and allowing them to swell for 1 h at 51°C. Sonication, phosphorus determination, and vesicle-size analysis were performed as described above. Re-LPS was hydrated for 1 h at 41°C in 5 mM Tris-HCl buffer (pH 7.4), containing 150 mM NaCl, and 0.1 mM EDTA and sonicated during 2 min.
LPS aggregation or DPPC/DPPG vesicle aggregation induced by SP-A was studied either at 25 or 37°C by measuring the change in absorbance at 400 nm in a Beckman DU-640 spectrophotometer. SP-Ainduced LPS aggregation assays were performed as described elsewhere (22, 23) . Briefly, the sample and reference cuvettes were first filled with Re-LPS (40 g/ml, final concentration) in 5 mM Tris-HCl buffer (pH 7.4), 150 mM NaCl, 0.2 mM EDTA. After a 10-min equilibration at 25°C (or 37°C), SP-A (20 g/ml) was added to the sample cuvette, and the change in optical density at 400 nm was monitored. Next, Ca 2ϩ (2.5 mM) was added to both the sample and reference cuvettes, and the change in absorbance was monitored again. Ca 2ϩ -dependent LPS aggregation was reversed by adding EDTA (5 mM, final concentration). For SP-A-induced phospholipid vesicle aggregation assays, the final concentrations of SP-A, phospholipid, calcium, and EDTA were 20 g/ml, 100 g/ml, 2.5 mM, and 5 mM, respectively.
Adsorption Assay-The ability of recombinant SP-A1 and SP-A1 ⌬AVC,C6S to enhance the adsorption of lipid extracts of porcine surfactants (LES) onto an air-liquid interface was performed on a Wilhelmy-like high sensitive surface microbalance, coupled to a small Teflon dish as previously reported (22) . Lipid extracts of surfactant (LES), which contain surfactant lipids, SP-B, and SP-C, were prepared by chloroform/methanol extraction (37). The organic solvent was then evaporated to dryness under a stream of nitrogen, and traces of solvent were subsequently removed by evacuation under reduced pressure overnight. Multilamellar vesicles of LES were prepared by hydrating the dry proteolipid film in a buffer containing 150 mM NaCl, 25 mM Hepes, pH 6.9, and allowing them to swell for 1 h at 51°C. After vortexing, the resulting multilamellar vesicles were used for the adsorption assay. Briefly, SP-A (7 g/ml) was first added into the hypophase chamber of the Teflon dish, which contained 6 ml of 25 mM Hepes buffer, pH 6.9, 150 mM NaCl, and 5 mM CaCl 2 . After LES injection (70 g of phospholipids/ml) into the hypophase, phospholipid interfacial adsorption was measured following the change in surface tension as a function of time at 25°C. Total phospholipid in LES was determined by phosphorus analysis.
Cell Assays-Monocyte-like U937 cells were grown in RPMI 1640 supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM glutamine, and penicillin G sodium (100 units/ml)/streptomycin sulfate (100 g/ml), and 0.25 g/ml amphotericin B under a 95% air-5% CO 2 humidified atmosphere at 37°C. The medium was changed every 48 h. U937 cells were dispensed into 24-well plates at 1 ϫ 10 6 cells/ml and differentiated into macrophages by incubation with 10 nM phorbol 12-myristate 13-acetate for 24 h at 37°C in a 5% CO 2 humidified atmosphere. Then cells were washed with medium, and, 24 h later, cells were washed and pretreated with increasing concentrations (1-20 g/ ml) of SP-A for 10 min prior to 4-h Re-LPS (100 ng/ml) stimulation in the presence of 2% of heat-inactivated FBS at 37°C. In another set of experiments, differentiated U937 cells were stimulated with smooth LPS (1 g/ml), which hardly bound to SP-A. In some experiments, cells were pretreated with either 1 g/ml anti-CD14 alone or in combination with SP-A for 10 min prior to 4-h LPS stimulation. Cell viability was confirmed by trypan blue exclusion.
For measurement of TNF-␣ production, cell-free culture supernatants were collected and assayed for TNF-␣ with an enzyme-linked immunoassay kit (OptEIA Set human TNF-␣, BD Pharmingen). Four different cell cultures were used (n ϭ 4). The assays from each U937 cell culture were performed in triplicate, the triplicate values were averaged, and their mean treated as a single point. The results are presented as the means (ϮS.E.), obtained by combining the results from each cell preparation. Results were expressed as a percentage of the level of TNF-␣ production by cells stimulated with LPS in the absence of SP-A.
For FITC-LPS binding assays, differentiated U937 cells (0.3 ϫ 10 6 cells/ml) (96-well plates) were pretreated with 20 g/ml SP-A for 10 min prior to 20-min FITC-LPS (1 g/ml) incubation in the presence of 2% of heat-inactivated FBS at 37°C. In some experiments, cells were pretreated with either 1 g/ml anti-CD14 alone or in combination with SP-A for 10 min prior to 20-min FITC-LPS incubation. For measurement of cell-associated fluorescence, cultures were immediately washed three times with 300 l of cold PBS. Then 100 l of 0.2 mg/ml trypan blue in PBS were added to quench extracellular fluorescence, and the fluorescence intensity was measured in a Fluostar microplate reader at 485 nm excitation and 530 nm emission wavelength. Three different cell cultures were used, and the assays from each U937 cell culture were performed in quadruplicate. Results are presented as the means (ϮS.E.). For statistical analysis, mean comparison between groups was done by one-way analysis of variance followed by Bonferroni post hoc analysis; a confidence level of 95% or greater (p Ͻ 0.05) was considered significant.
RESULTS

Structural Characterization of SP-A1 ⌬AVC,C6S -Recombinant human SP-A1 and SP-A1
⌬AVC,C6S were expressed in CHO cells. Wild type recombinant SP-A1 had supratrimeric structure and was Asn 187 -glycosylated and prolyl-hydroxylated (22) .
SP-A1
⌬AVC,C6S was efficiently secreted into the culture medium. Given its low binding affinity to a mannose-Sepharose affinity column in the presence of calcium, a new purification scheme was developed using anionic exchange, size exclusion, and hydrophobic interaction chromatography.
The NH 2 -terminal sequences of SP-A1 and SP-A1
⌬AVC,C6S
were determined by protein microsequencing. The results are summarized in Table I . SP-A1 showed three NH 2 -terminal isoforms. Polypeptide subunits starting at position ϩ1 (Glu) represented 50% of the protein, whereas isoforms with an additional Val Ϫ2 -Cys Ϫ1 (VC isoform) and Ala Ϫ3 -Val Ϫ2 -Cys
Ϫ1
(AVC isoform) comprised 30 and 20%, respectively. In these three isoforms, the sequence of amino acids from positions ϩ1 to ϩ7 was identical to the reported NH 2 -terminal sequence for human SP-A (SP-A1 or SP-A2). On the other hand, the combined mutant SP-A1 ⌬AVC,C6S started at position ϩ1 (Glu), and the sequence of amino acids to position ϩ7 and beyond was identical to SP-A1, except for the substitution of Ser for Cys 6 . Oligomerization was assessed by size exclusion chromatography, electrophoresis under non-denaturing conditions, and electron microscopy. The recombinant expression of this construct in CHO K1 cells yielded SP-A1 ⌬AVC,C6S in trimeric form (Fig. 1) . Fig. 1 (A and B) show electron microscopy images of recombinant SP-A1 and SP-A1 ⌬AVC,C6S , respectively, using the rotatory shadowing technique. SP-A1 consisted of a heterogeneous population of supratrimeric oligomers (ranging from nonamers up to octadecamers) (Fig. 1A) . In contrast, SP-A1 ⌬AVC,C6S consisted of a homogeneous population of trimers. For some particles in side view, rod-like structures and globular domains are clearly observed (Fig. 1B) . The rod-like structures would correspond to the neck domain, collagen-like region, and NH 2 -terminal segments of the three polypeptide chains that form the trimer as it is graphically represented in Fig. 1 . The trimeric structure of SP-A1
⌬AVC,C6S was confirmed by size exclusion chromatography (data not shown) and nondenaturing electrophoresis (without SDS or heat treatment) under non-reducing conditions (Fig. 1C) . This study corroborated that SP-A1
⌬AVC,C6S consisted of trimers (lane b), whereas wild-type SP-A1 (lane a) or natural SP-A isolated from alveolar proteinosis patients (lane c) consisted of supratrimeric oligomers.
To identify disulfide-linked polypeptide chains in SP-A1
⌬AVC,C6S trimers, we performed SDS gradient gel electrophoresis under non-reducing conditions (Fig. 1D) . The trimeric SP-A1 ⌬AVC,C6S (lane b) exhibited two major bands corresponding to two and three disulfide-linked chains, respectively, and a faint band corresponding to monomers. These results proved that part of the SP-A1 ⌬AVC,C6S trimers contained two polypeptide chains covalently linked by at least one disulfide bond, and part of the SP-A1 ⌬AVC,C6S trimers contained the three polypeptide chains cross-linked by two disulfide bonds. This indicates that Cys 48 (located at the Pro-Cys-Pro-Pro interruption between the two collagen-like regions) as well as Cys 65 (located at the C-terminal half of the collagen-like domain) contributed to these intra-trimer disulfide bonds. On the other hand, the (lanes a and b) shows that polypeptide chains of human SP-A1 and SP-A1
⌬AVC,C6S exhibited similar mobility as detected in SDS-PAGE under reducing conditions. The slight difference in mobility between monomeric recombinant forms (lanes a and b) , and natural SP-A (lane c) was due to the higher degree of glycosylation in CHO K1 cells. Fig. 2A shows that recombinant human SP-A1 ⌬AVC,C6S trimers had circular dichroism (CD) spectra at low temperature comparable in shape and magnitude to published spectra for recombinant human SP-A1 and natural SP-A from healthy subjects or alveolar proteinosis patients (22) . The thermal denaturation of the collagen triple helix of SP-A1
⌬AVC,C6S , monitored by CD spectroscopy, is shown in Fig. 2B along with that of wild type SP-A1, which has been reported recently (22) . The 
a Numbered according to the position in the reported native SP-A sequence. b Calculated using the molecular yield (picomoles) of representative amino acids from each sequence divided by the molecular yield (picomoles) of total isoforms (e.g. % sequence 1 isoform ϭ pmol sequence 1/pmol sequence 1 ϩ pmol sequence 2 ϩ pmol sequence 3).
c Hyp, hydroxyproline.
FIG. 1.
A and B, electron micrographs after rotary shadowing of recombinant human SP-A1 and SP-A1
⌬AVC,C6S
, respectively, expressed in CHO K1 cells. The bars indicate a length of 50 nm. 25 ng of both SP-A1 and SP-A1 ⌬AVC,C6S were subjected to electron microscopy as described in Ref.
The different degrees of oligomerization of SP-A1 and SP-A1
⌬AVC,C6S are also graphically represented. C-E, electrophoretic analysis of recombinant human SP-A1 (lane a), recombinant human SP-A1
⌬AVC,C6S mutant (lane b), and human SP-A from alveolar proteinosis patients (lane c). C, a Western blot after the separation of the SP-As on a 7% polyacrylamide gel under native conditions. The amount of each protein loaded was 100 ng. D, a Western blot after 4 -12% SDS-PAGE under non-reducing conditions to identify disulfide-linked polypeptide chains. The amount of each protein loaded was 50 ng. In E, proteins (1 g of each SP-A preparation) were subjected to 12% SDS-PAGE under reducing conditions and visualized by silver staining. Numbers on the right denote molecular mass.
collagen triple helix of SP-A1
⌬AVC,C6S melted at a midpoint temperature (T m ) of 32.7 Ϯ 1°C (n ϭ 3). In contrast, the collagen triple helix of SP-A1 melted in a narrower temperature range than that of SP-A1 ⌬AVC,C6S and at a midpoint temperature of 44.5 Ϯ 0.3°C (n ϭ 3). Under physiological ionic conditions (in the presence of 1 mM calcium and 150 mM NaCl) the T m of both SP-A1
⌬AVC,C6S and SP-A1 did not change significantly, showing T m values of 33.3 Ϯ 3.7°C (n ϭ 3) and 48.1 Ϯ 3.6°C (n ϭ 3) for SP-A1
⌬AVC,C6S and SP-A1, respectively. Collectively, these data clearly indicated that a supratrimeric structure stabilized by NH 2 -terminal disulfide bonds was important for the stabilization of the triple helix at physiological temperatures.
Next we examined the SP-A temperature-dependent susceptibility to trypsin degradation to further characterize the collagen triple helix stability of SP-A1 ⌬AVC,C6S in comparison with wild type SP-A1. This technique was commonly used to characterize the effect of mutations on collagen triple helix stability in SP-D (25) and in type I collagen (38) . The polypeptide chain of mature SP-A1 contains 20 trypsin cleavage targets; nine of them are located in the NH 2 -terminal segment, collagen-like domain, and neck. Fig. 3 shows that both wild type SP-A1 and SP-A1 ⌬AVC,C6S mutant were less susceptible to trypsin degradation following incubation at temperatures below their collagen melting temperatures (T m ) than above them. Thus, SP-A1 ⌬AVC,C6S was much more susceptible than SP-A1 to trypsin degradation at 37°C. These results are consistent with the finding that the collagen triple helix of the Cys 6 mutant was partially unfolded at 37°C, which increased the susceptibility of the protein to proteolytic degradation. Fig. 3 also shows that the susceptibility to trypsin of wild type SP-A1 was similar at 25 and 37°C (temperatures below its T m : 44.5°C) and was less than that of SP-A1 ⌬AVC,C6S mutant at 25°C, which suggests that the formation of the microfibrillar end piece of octadecamers restricts the accessibility of trypsin to some of its cleavage sites even more.
Binding of SP-A to Its Ligands-The binding of SP-A1 and SP-A1
⌬AVC,C6S to calcium was followed by changes in SP-A fluorescence emission intensity and by spectral shifts on excitation at 275 nm at 25°C (Fig. 4A) . The fluorescence of SP-A is dominated by the contribution of its two conserved tryptophan residues (29) located at positions 191 and 213 of the globular COOH-terminal domain. The two SP-A tryptophans are located near the calcium binding site (13) , being sensitive markers of conformational changes in this region (22, 23, 36, 39) . Fig. 4A shows that SP-A1 and SP-A1 ⌬AVC,C6S showed identical fluorescence emission spectra in the absence of calcium, suggesting the absence of abnormalities of the COOH-terminal end of the SP-A1
⌬AVC,C6S molecule. Upon addition of calcium, the fluorescence emission spectrum of both proteins showed an increase in fluorescence intensity accompanied by a blue-shift of the wavelength emission maximum from 330 (in the presence of EDTA) to 326 nm. This signified that the addition of calcium caused a conformational change in both proteins decreasing polarity in the environment of the tryptophan residues. The fact that both proteins showed similar fluorescence properties upon addition of calcium indicated that the degree of oligomerization did not affect the binding of calcium to the globular domains of SP-A. This was expected, because it was reported that calcium efficiently binds to the collagenase-resistant fragment of human SP-A (39).
The conformational change induced by calcium was also evaluated by protein susceptibility to trypsin degradation (Fig.  4B) . Control experiments with serum albumin indicated that trypsin activity was not dependent on Ca 2ϩ (data not shown). The binding of calcium to either SP-A1 or SP-A1 ⌬AVC,C6S markedly decreased the extent of digestion of these proteins by trypsin in comparison with the extent of SP-A degradation in the absence of calcium (Fig. 3) . These results suggest that the binding of calcium to its two binding sites in the globular head (13) , and likely to a binding site outside the globular head (39) , potentially located at a distinctive anionic patch between the collagen-like domain and the coiled-coil neck region (13), modifies protein conformation because the accessibility of trypsin cleavage targets of SP-A1 or SP-A1 ⌬AVC,C6S was notably reduced. The presence of calcium also decreased the susceptibility to proteolysis of a collagenase-resistant fragment of human SP-A (39) . Fig. 4B also shows that, in the presence of calcium, supratrimeric SP-A1 was more resistant to trypsin degradation than trimeric SP-A1
⌬AVC,C6S , especially at 37°C, a tempera-
FIG. 2. A, circular dichroic spectra of SP-A1
⌬AVC,C6S at 10 and 70°C in 5 mM Tris-HCl buffer, pH 7.4. B, unfolding curves of SP-A1 and SP-A1
⌬AVC,C6S
. Melting curves were monitored at 207 nm, at 120 g of SP-A/ml, whereas the sample temperature was raised from 10 to 70°C, with an average heating rate of 12°C/h. The folded fraction (F) was calculated as described under "Experimental Procedures." The temperature where F ϭ 0.5 was taken as the melting temperature (T m ). The results shown are from a representative one of three experiments.
FIG. 3. Protease sensitivity of wild type recombinant human SP-A1 (W) and the SP-A1
⌬AVC ture at which the collagen domain of SP-A1 ⌬AVC,C6S is partially unfolded (T m : 33.3°C in the presence of 1 mM calcium and 150 mM NaCl) and, therefore, the accessibility of trypsin to its cleavage sites at the collagen domain is greater.
The binding of SP-A to DPPC membranes was monitored as the fluorescence resonance energy transfer (FRET) from SP-A tryptophan residues (donor) to an appropriate acceptor such as a dansyl group located in the DPPC vesicle surface. This process is dependent on the proximity between donor and acceptor. The binding of different SP-As (natural SP-A, SP-A1, and SP-A1 ⌬AVC,C6S ) to DPPC vesicles was determined on excitation at 282 nm while monitoring the increase of dansyl fluorescence as a result of FRET (Fig. 5A) . Two types of experiments were done: (a) the DPPC/SP-A weight ratio was held constant while increasing the amount of dansyl-DHPE incorporated in DPPC vesicles (Fig. 5B) and (b) the dansyl-DHPE/DPPC ratio was held constant while increasing the DPPC/SP-A weight ratio (Fig. 5C) . These experiments clearly indicated that SP-A1 ⌬AVC,C6S was able to bind to DPPC vesicles. The binding increased as a function of mol% of dansyl group-incorporated in DPPC vesicles (Fig. 5B) and as a function of the DPPC/SP-A1 ⌬AVC,C6S weight ratio (Fig. 5C ) as was observed for either natural SP-A or wild type SP-A1. These results indicated that supratrimeric assembly was not essential for the binding of SP-A to phospholipid vesicles.
The binding of SP-A to rough-LPS in solution was followed by changes in FITC-Re-LPS fluorescence properties such as intensity and anisotropy (Fig. 6) . FITC-Re-LPS has been widely used to study the interaction of LPS-binding proteins with rough-LPS (40, 41) . Fig. 6A shows the time dependence of the fluorescence change when fluorescent rough-LPS (4 ϫ 10 Ϫ7 M) reacts with a 3.5-fold excess of either SP-A1 or SP-A1 ⌬AVC,C6S (13.8 ϫ 10 Ϫ7 M, considering the molecular weight of SP-A monomer). The magnitude of the fluorescence change after SP-A addition clearly increased with higher degree of oligomerization. Control experiments were done with free fluorescein to demonstrate that all of these changes did not result from the interaction of the different SP-As with the dye (fluorescein), but with the LPS molecule (data not shown). We also examined the binding of different SP-As to FITC-Re-LPS by measuring fluorescence anisotropy of the fluorescently labeled LPS molecule (Fig. 6B) . Fluorescence anisotropy measurements depend on the rate and extent of the rotational motion of the fluorophore during the lifetime of the excited state. FITC-Re-LPS possessed an emission anisotropy of around 0.067 Ϯ 0.003 (x ϭ 470 nm; m ϭ 520 nm) in 5 mM Tris-HCl buffer, pH 8, containing 100 mM NaCl, 1 mM EDTA, at 25°C. The formation of FITC-Re-LPS/SP-A complexes led to a significant increase of fluorescence emission anisotropy, indicating that the binding of SP-A1 or SP-A1
⌬AVC,C6S to Re-LPS caused mechanical restrictions of the rotational mobility of the dye. The higher increase in anisotropy of FITC-Re-LPS bound to SP-A1 could be attributed to a more restricted movement of the labeled LPS molecule when it is bound to supratrimeric SP-A1. Control experiments with free fluorescein indicated that the SP-A-induced increase in FITC-Re-LPS fluorescence anisotropy was due to the binding of SP-A to Re-LPS but not to the fluorescent probe. Fig. 7A shows that the cysteine mutant does not selfassociate in the presence of calcium at 25°C (or 37°C), indicating that a supratrimeric assembly is needed for this activity. In addition, SP-A1 ⌬AVC,C6S did not induce Re-LPS aggregation (Fig. 7B ) and phospholipid vesicle aggregation (Fig. 7C) despite the fact that SP-A1 ⌬AVC,C6S was able to bind to both Re-LPS and phospholipids. These data strongly suggest that the ability of SP-A to induce Re-LPS and phospholipid vesicle aggregation might correlate with the capability of SP-A to self-associate in the presence of calcium. All of these processes required the protein to be in a supratrimeric assembly. Fig. 8 shows the change in surface pressure as a function of time for reconstituted surfactant-like membranes (containing SP-B and SP-C) in the absence and presence of SP-A1 and SP-A1 ⌬AVC,C6S . SP-A1 ⌬AVC,C6S poorly affected the interfacial adsorption rate of surfactant-like membranes. In contrast, SP-A1 highly enhanced the adsorption rate, reaching the equilibrium surface pressure (47 millinewtons/m) at 20 min, as previously reported (22) . Much longer times would be needed to reach the equilibrium surface pressure for reconstituted lipid extract alone or in the presence of SP-A1 ⌬AVC,C6S . These results revealed that the SP-A-induced enhancement of surfactant interfacial adsorption is dependent on the supratrimeric structure of SP-A.
SP-A Self-association and SP-A-induced Ligand Aggregation-
SP-A-induced Enhancement of Surfactant Interfacial Adsorption Rate-
SP-A-induced Inhibition of TNF-␣ Production by Rough or Smooth LPS-stimulated U937
Cells-To investigate the effect of the degree of oligomerization on the anti-inflammatory activity of SP-A, increasing amounts (1-20 g/ml) of recombinant forms of human SP-A (SP-A1 and SP-A1 ⌬AVC,C6S ) were preincubated with macrophage-like cells 10 min prior to 4-h activation with an optimal concentration of rough-LPS (100 ng/ml) (Fig. 9A ). An appropriate amount of heat-inactivated FBS (2%) was included in the medium. The inhibitory effect of SP-A1 and SP-A1
⌬AVC,C6S upon rough LPS-induced TNF-␣ secretion depended upon the SP-A concentrations. Concentrations as low as 5 g/ml of either supratrimeric SP-A1 or trimeric SP-A1
⌬AVC,C6S significantly inhibited TNF-␣ production by about 90 and 49%, respectively. None of these SP-As alone had any effect on TNF-␣ production by resting differentiated U937 cells for 4 h after SP-A addition (data not shown). The inhibitory effect of SP-A1 on LPS-induced TNF-␣ secretion was similar to 
FIG. 7.
A, kinetics of Ca 2ϩ -dependent self-association of SP-A1 (E) and SP-A1 ⌬AVC,C6S (•). Recombinant human SP-As (20 g/ml) were added to the sample cuvette filled with 5 mM Tris-HCl buffer (pH 7.4). The turbidity change at 360 nm was monitored at 25°C (or 37°C) at 1-min intervals. After stabilization, 5 mM Ca 2ϩ (final concentration) was added to both the sample and reference cuvette, and the turbidity changes monitored again. Addition of EDTA (10 mM, final concentration) dissociated SP-A1 aggregates induced by Ca 2ϩ . B, kinetics of Ca 2ϩ -dependent Re-LPS aggregation in the absence (ƒ) or presence of SP-A1 (E) and SP-A1 ⌬AVC,C6S (•). The experiments were done as described under "Experimental Procedures" in 5 mM Tris-HCl buffer (pH 7.4), 150 mM NaCl, at 25°C. The final concentrations of SP-A, Re-LPS, calcium, and EDTA were 20 g/ml, 40 g/ml, 2.5 mM, and 5 mM, respectively. C, kinetics of DPPC/DPPG vesicle aggregation induced by SP-A in the presence of calcium. Experiments with vesicles alone (ƒ) or in the presence of SP-A1 (E) and SP-A1 ⌬AVC,C6S (•) are shown. The experiments were done as described under "Experimental Procedures" in 5 mM Tris-HCl buffer (pH 7.4), 150 mM NaCl, at 25°C. The final concentrations of SP-A, DPPC/DPPG vesicles, and calcium were 20 g/ml, 100 g/ml, and 2.5 mM, respectively. In A-C one representative experiment of three experiments is shown. that of 1 g/ml 28C5, an anti-CD14 antibody that has been shown to block Re-LPS binding to CD14 (41, 42) (data not shown).
To determine whether part of the anti-inflammatory effect of SP-A1 could be due to the ability of SP-A1, but not of SP-A1 ⌬AVC,C6S , to induce Re-LPS aggregation in the presence of calcium, which would reduce LPS toxicity (43), we also used a smooth serotype of LPS to stimulate macrophage-like U937 to which SP-A hardly binds (44) . Fig. 9B shows that concentrations of both SP-A1 and SP-A1 ⌬AVC,C6S equal to or higher than 5 g/ml inhibited smooth LPS-induced TNF-␣ production by about 90 and 69%, respectively. Together, these results indicate that the anti-inflammatory activity of SP-A requires only assembly of a trimer.
On the other hand, our results on the effect of SP-A on the membrane binding of FITC-LPS by differentiated U937 coincided with those of Stamme et al. (45) , who found that human SP-A significantly decreased association of rough [
3 H]Rb-LPS to mCD14-transfected HEK cells in the presence of 5% serum. Fig. 10 shows that both SP-A1 and SP-A1 ⌬AVC,C6S equally decreased the fluorescence associated to macrophage-like U937 cells by 80% in the presence of 2% serum. Anti-CD14 -28C5 (1 g/ml), which has been shown to mask the LPS binding site on CD14 (41, 42) , similarly hampered the FITC-LPS binding to U937 cells. These data suggest that the SP-A-induced inhibition of smooth or rough LPS inflammatory response might be, at least in part, mediated by blocking the binding of LPS to its cellular receptor complex.
DISCUSSION
The aim of this study was to investigate the effect of the degree of oligomerization on the structural and functional properties of mammalian cell-derived human SP-A1. To obtain human SPA1 trimers, the cysteine at position ϩ6 of human SP-A1 was removed by site-directed mutagenesis (serine was substituted for cysteine 6), and the cysteinyl isoforms (containing Cys Ϫ1 ) were abolished by replacing SP-A1 signal sequence with human IgG light-chain signal sequence. The rationale for this strategy is based on the fact that individual rat SP-A disruption of Cys 6 (17) or Cys Ϫ1 (18) by substitution with Ser did not prevent the assembly of supratrimeric SP-A as detected by cross-linking analyses and gel exclusion chromatography. In addition, it is thought that at least two or three cysteine residues have to be present in the NH 2 -terminal domain of collectins (mannose-binding protein-A, conglutinin, SP-D, and rat SP-A) to form disulfide-linked supratrimeric oligomers (17, 18, 25, 26, 46) . However, there are some departures from this assumption: CL-43 is secreted as a trimer despite having two NH 2 -terminal cysteine residues in exactly the same positions as SP-D (Cys 15 and Cys 20 ); and canine SP-A, which has only one NH 2 -terminal cysteine residue (Cys 6 ), assembles into higher oligomers. The mechanism by which trimers assemble into larger oligomers is still unclear. It is believed that, besides the number of NH 2 -terminal cysteines, residues within the NH 2 -terminal segment and the NH 2 -terminal region of the collagen-like domain might also contribute to the oligomerization of trimeric subunits (46 -48) .
The combined mutation used in this study eliminates potential sites of inter-chain disulfide cross-linking within the most NH 2 -terminal portion of human SP-A. The analysis of the NH 2 -terminal sequence of recombinant forms of human SP-A1 indicates that the combined mutant SP-A1 ⌬AVC,C6S started at position ϩ1 (Glu) of the reported NH 2 -terminal sequence for human SP-A, whereas SP-A1 was composed of Cys Ϫ1 isoforms which contained amino acid extensions derived from its signal peptide. Polypeptide subunits of SP-A1 starting at Glu 1 represent 50% of the protein, whereas isoforms containing Cys
Ϫ1
(VC and AVC isoforms) represent the remaining 50%. Cys Ϫ1 may contribute to the supratrimeric assembly by intra-or intertrimer disulfide cross-linking in the NH 2 -terminal portion of the molecule.
The recombinant expression of this combined mutant in mammalian CHO K1 cells yielded SP-A1 ⌬AVC,C6S in trimeric form, identified by size exclusion chromatography, electron microscopy, and non-denaturing electrophoresis. Electron microscopy showed that SP-A1 ⌬AVC,C6S assembled as a single arm of the supratrimeric recombinant human SP-A1 molecule, which consisted of octadecamers (six-armed), dodecamers (four-armed), and nonamers (three-armed). These results suggest that disulfide bonds at the NH 2 -terminal segment of human SP-A seem to be required for the formation of oligomers of trimeric subunits. In the case of mammalian cell-derived mannose-binding protein-A, individual disruption of Cys 6 by substitution with Ser yielded mainly trimers but also hexamers and low levels of higher oligomers, indicating that other cysteine residues (Cys 13 and Cys 18 ) at the NH 2 -terminal segment also contribute to the supratrimeric assembly by intra-or intertrimer disulfide cross-linking (46) . On the other hand, the two cysteines of the NH 2 -terminal segment of rat SP-D (Cys 15 and Cys 20 ) seem to be required for the SP-D supratrimeric assembly into dodecamers (25) .
Polypeptide chains of SP-A1 ⌬AVC,C6S and SP-A1 have identical mobility in SDS-PAGE under reducing conditions. Likewise, disulfide-linked trimers and dimers of SP-A1
⌬AVC,C6S and SP-A1 have identical mobility on 4 -12% SDS-PAGE under nonreducing conditions. SP-A1
⌬AVC,C6S trimers have fluorescence and circular dichroism spectra comparable to those of supratrimeric SP-A1, indicating that trimeric SP-A1
⌬AVC,C6S
has structural characteristics similar to supratrimeric SP-A1. However, we found that the collagen triple helix of the cysteine mutant melted at lower temperature (32.7°C) than that of SP-A1, whose T m is 44.5 (22) . Both proteins, SP-A1 ⌬AVC,C6S and SP-A1, were much more resistant to trypsin degradation at temperatures below their collagen melting temperatures than above them. Consistently, the trypsin susceptibility of SP-A1 ⌬AVC,C6S was greater than that of wild type SP-A1 at 37°C. These results suggest that the lack of the supratrimeric assembly would yield to a partly unfolded SP-A at physiological temperatures that would be more susceptible to proteolytic degradation. Similar results were found with recombinant rat SP-D expressed in mammalian cells. A mutation of the NH 2 -terminal cysteines at positions 15 and 20 resulted in the production of trimers, with increased susceptibility to proteolytic degradation at 37°C (25) . It is possible that oxidative cleavage of disulfide bonds at the NH 2 -terminal segment, by exposing the lungs to environmental pollutants (e.g. ozone, SO 2 , or nitrogen oxides), affects the supratrimeric assembly of SP-A or SP-D along with other conformational changes.
SP-A binds to phospholipid vesicles that contain DPPC, and the major lipid binding site resides in the globular domain (2, 12, 13) . The capability of SP-A1 ⌬AVC,C6S , SP-A1, and natural human SP-A to bind to DPPC vesicles was analyzed by fluorescence resonance energy transfer from SP-A tryptophan residues to a dansyl group located in the DPPC vesicle surface. These analyses indicated that supratrimeric assembly was not essential for the binding of SP-A to phospholipids. Importantly, the trimeric SP-A1
⌬AVC,C6S was unable to induce phospholipid vesicle aggregation in the presence of calcium despite the fact that this protein was able to bind to phospholipids and calcium. These results indicate that Ca 2ϩ -dependent phospholipid vesicle aggregation induced by human SP-A requires the protein to be in a supratrimeric assembly.
The mechanism involved in the vesicle aggregation phenomenon is poorly understood. It is likely that vesicle aggregation activity of human SP-A is related to the ability of the highly multimerized protein to cross-link different vesicles. At the same time, the ability of human SP-A to self-associate in the presence of calcium would greatly increase the vesicle aggregation activity of SP-A. Here we demonstrated that the cysteine mutant did not undergo self-association in the presence of calcium, and it was unable to induce aggregation of membranes, which supports the concept that both processes are related phenomena. Haagsman et al. (39) proposed that the lipoprotein aggregation induced by calcium could be mediated by Ca 2ϩ -induced self-association of human SP-A molecules. In addition, we found that the calcium activation constant (K a Ca2ϩ ) for both processes is similar at physiological ionic strength and is in the range of 1-2 M (33, 36). Our current understanding is that calcium causes conformational changes in the globular domain of SP-A detected by fluorescence spectroscopy (22, 36, 39) and transmission electron microscopy (49) . We propose a model for self-association of supratrimeric SP-A in which, upon binding to Ca 2ϩ , protein association occurs among adjacent globular heads and nearby regions provided that a supratrimeric assembly and a structurally intact collagen domain (22, 36) ensure the correct grouping and orientation of globular heads in the oligomer. Self-associated SP-A molecules would connect surfactant membranes by interaction of their globular heads with membrane surfaces of contiguous bilayers. SP-A protein networks interacting with monolayers of surfactant phospholipids are visible by transmission electron microscopy (50) or epifluorescence microscopy (51) . This type of calcium-dependent supraquaternary organization of supratrimeric SP-A and cooperative interaction with surfactant membranes could stabilize large surfactant aggregates, decrease surfactant inactivation in the presence of serum protein inhibitors, and facilitate interfacial adsorption of surfactant.
Related to the ability of SP-A to enhance the interfacial adsorption rate of surfactant-like membranes, the results presented here revealed that SP-A1
⌬AVC,C6S did not promote the spreading of SP-B/SP-C-surfactant membranes along the surface. These results support the idea that the capability of SP-A ⌬AVC,C6S (closed circles) for 10 min prior to 4 h activation with either 100 ng/ml rough-LPS (A) or 1 g/ml smooth-LPS (B), in the presence of 2% fetal bovine serum, at 37°C. Cell-free supernatants were collected at 4 h after LPS treatment, and the levels of TNF-␣ were measured by using an enzyme-linked immunosorbent assay kit. Data presented are from four different cell cultures (n ϭ 4). The assays from each U937 cell culture were performed in triplicate, the triplicate values were averaged, and their mean treated as a single point. The results are presented as the means (ϮS.E.). Results were expressed as a percentage of LPS-induced TNF-␣ levels. *, p Ͻ 0.05 compared with response elicited by LPS in the absence of SP-A.
FIG. 10. Effect of SP-A1 and SP-A1
⌬AVC,C6S on FITC-LPS binding by macrophage-like U937 cells. Differentiated U937 cells (0.3 ϫ 10 6 cells/ml) were preincubated in the absence (gray bar) or presence of either 1 g/ml anti-CD14 (28C5) (shaded bar), 20 g/ml SP-A1 (open bar), or 20 g/ml SP-A1 ⌬AVC,C6S (closed bar) for 10 min prior to 20-min incubation with FITC-LPS (1 g/ml) in the presence of 2% of heatinactivated FBS, at 37°C. For measurement of cell associated fluorescence, cultures were immediately washed three times with 300 l of cold PBS, and then with 100 l of 0.2 mg/ml trypan blue in PBS. Fluorescence emission intensity was measured at 485 nm excitation and 530 nm emission wavelengths. Data presented are from three different cell cultures. The assays from each U937 cell culture were performed in quadruplicate. The results are presented as the means (Ϯ S.E.). *, p Ͻ 0.05 versus control.
to self-associate and to induce phospholipid aggregation predicts the surface active properties of the protein in concerted action with SP-B (28). Collectively, our results suggest that surfactant-related activities of SP-A depend on the supratrimeric assembly of the protein. Consistent with this assumption is a recent in vivo study that indicates that the SP-A collagendeficient mutant expressed in the lungs of SP-A null (SP-A Ϫ/Ϫ ) mice converts SP-A into an inhibitor of surfactant function (52) . In vitro studies show that the collagen-deficient mutant of SP-A is expressed as a trimer (53) , suggesting that the collagen-like region and/or supratrimeric assembly play an important role in the accommodation of SP-A in the alveolar lipidrich fluid.
The large excess of SP-A and SP-B/SP-C-surfactant membranes in the lung air spaces minimizes the biological effects of endotoxins, such as LPS, or microbes that enter the alveolus. SP-A binds to rough LPS and induces rough-LPS aggregation in the presence of calcium (44) . Aggregation of LPS reduces LPS toxicity (43) and facilitates phagocytosis by alveolar macrophages (54) . We found that the binding of human SP-A to FITC-Re-LPS increased with the degree of oligomerization, but supratrimeric assembly was not essential. Despite the ability of trimeric SP-A1
⌬AVC,C6S to bind to Re-LPS, this mutant was unable to induce Re-LPS aggregation in the presence of calcium, indicating that the supratrimeric assembly of SP-A is required for this activity. We propose that Re-LPS or bacteria aggregation induced by SP-A is enhanced by SP-A self-association dependent on calcium. Accordingly, self-associated SP-A would bind to endotoxins or bacteria by the globular heads, resulting in bacterial aggregation, whereas the collagen tails of these aggregates would be free to interact with receptors on the surface of macrophages initiating phagocytosis and inflammatory responses (9) . Moreover, Gardai et al. (9) suggested that significant self-association of SP-A is required for the optimal stimulation of macropinocytosis induced by interaction of SP-A collagen tails with the calreticulin/CD91 system on the surface of phagocytic cells. Results indicated that agglutination and phagocytosis of inhaled pathogens or toxins mediated by SP-A might depend on the supratrimeric assembly of the protein.
We also have analyzed the effect of the degree of oligomerization on the anti-inflammatory activity of SP-A, which is responsible for maintaining low alveolar inflammation in the resting lung by causal stimuli such as low concentrations of inhaled LPS. We found that both SP-A1 and SP-A1 ⌬AVC,C6S , at concentrations equal to or higher than 5 g/ml, significantly inhibited TNF-␣ production by macrophage-like cells stimulated by either rough LPS, to which they bind, or smooth LPS, to which they hardly bind. In addition, both SP-A1 and SP-A1 ⌬AVC,C6S hampered the binding of FITC-LPS to macrophagelike U937 cells in a manner similar to anti-CD14 -28C5, an anti-CD14 antibody that has been shown to block Re-LPS binding to CD14 (41, 42) . Altogether, these data indicate that supratrimeric assembly of SP-A was not required for the antiinflammatory effects of SP-A. SP-A-induced inhibition of smooth or rough LPS inflammatory response might be, at least in part, mediated by blocking the binding of LPS to its cellular receptor complex since SP-A binds to CD14 by its neck domain (55) . Alternatively, SP-A, through its globular heads, could bind to signal inhibitory regulatory protein ␣, expressed by mononuclear phagocytes, to initiate a signal pathway that blocks pro-inflammatory cytokine production as recently reported by Gardai et al. (9) .
In summary, this study indicated for the first time that a supratrimeric assembly of human SP-A was important for the thermal stability of the protein at physiological temperatures and SP-A protection against trypsin degradation. SP-A supratrimeric assembly was essential for Ca 2ϩ -dependent SP-A self-association, SP-A-induced aggregation of phospholipid vesicles and LPS micelles, and SP-A-promoted adsorption of SP-B/SP-C-surfactant membranes to an air-liquid interface. However, supratrimeric assembly was not essential for the role of SP-A in the inhibition of rough or smooth LPS inflammatory response, which likely involves SP-A binding to cellular receptors by its globular and/or neck domains (9, 55) .
